danger in the water theodore marras md frcpc university of toronto & university health network
TRANSCRIPT
![Page 1: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/1.jpg)
![Page 2: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/2.jpg)
Danger in the Water
Theodore MarrasMD FRCPC
University of Toronto&
University Health Network
![Page 3: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/3.jpg)
Potential conflicts of interestFinancial – noneOther – clinical and academic interest in
pulmonary NTM disease (especially epidemiology, long term outcomes)
Off label use of therapiesNone of the medications mentioned have a
formal indication for the treatment of pulmonary NTM disease
Declarations
![Page 4: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/4.jpg)
1. Identify relevant potential infective exposures
2. Review management of pMAC:– Recommended drug treatment
– Approach to comprehensive management
3. Review data on treatment outcomes
4. Combining knowledge of:– Environment / interventions (relevance, uncertainty)
– Treatment outcomes
… to better inform clinical decisions
Objectives- Pulmonary Mycobacterium avium complex (pMAC)
![Page 5: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/5.jpg)
Background
![Page 6: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/6.jpg)
Pulmonary NTM- Microbiology
NTM M.tb.
Where they live Environment (water, soil)
Infected host
Infection Environmental exposure / inoculation
Infective aerosols
Spread person-person?
No Yes
Pathogenic Weakly Strongly
Diagnosis
![Page 7: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/7.jpg)
Pulmonary NTM- Microbiology
NTM M.tb.
Where they live Environment (water, soil)
Infected host
Infection Environmental exposure / inoculation
Infective aerosols
Spread person-person?
No Yes
Pathogenic Weakly Strongly
Diagnosis
![Page 8: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/8.jpg)
Pulmonary NTM- Microbiology
NTM M.tb.
Where they live Environment (water, soil)
Infected host
Infection Environmental exposure / inoculation
Infective aerosols
Spread person-person?
No Yes
Pathogenic Weakly Strongly
Diagnosis
![Page 9: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/9.jpg)
Pulmonary NTM- Microbiology
NTM M.tb.
Where they live Environment (water, soil)
Infected host
Infection Environmental exposure / inoculation
Infective aerosols
Spread person-person?
No Yes
Pathogenic Weakly Strongly
Diagnosis
![Page 10: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/10.jpg)
Pulmonary NTM- Microbiology
NTM M.tb.
Where they live Environment (water, soil)
Infected host
Infection Environmental exposure / inoculation
Infective aerosols
Spread person-person?
No Yes
Pathogenic Weakly Strongly
Diagnosis Micro + Micro
![Page 11: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/11.jpg)
Pulmonary NTM- Microbiology
NTM M.tb.
Where they live Environment (water, soil)
Infected host
Infection Environmental exposure / inoculation
Infective aerosols
Spread person-person?
No Yes
Pathogenic Weakly Strongly
Diagnosis Micro / Clin / Rad Micro
![Page 12: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/12.jpg)
“Disease” Criteria
Clinical Pulmonary symptoms, or
Nodules or cavities on CXR, or
Multifocal bronchiectasis & multiple small nodules on HRCT
(and exclusion of other diagnoses)
Micro With > 2 sputa 2 cultures +
With 1 BAL/wash 1 BAL/wash +
With biopsy • 1 biopsy culture +, or• 1 culture + and bx evidence of disease
Pulmonary NTM Disease- ATS / IDSA 2007
![Page 13: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/13.jpg)
Age and sex distribution
![Page 14: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/14.jpg)
Increasingly common disease of the elderly
in Ontario
![Page 15: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/15.jpg)
Where does it come from?
![Page 16: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/16.jpg)
• Moist environments– Natural and treated water– Soils
• Very disinfectant resistant
The Water we Drink- MAC
![Page 17: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/17.jpg)
![Page 18: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/18.jpg)
Hot Tub Lung:Hypersensitivity Pneumonitis to NTM
•Embil et al. Chest 1997 5
•Kahana et al. Chest 1997 1
•Mangione et al. Emerg Inf Dis 2001 5
•Case record NEJM 2000 1
•Khoor et al. Am J Clin Pathol 2001 10
•Rickman et al. Mayo Clin Proc 2002 2
•Cappelluti et al. Arch Intern Med 2003 1
•Pham et al. J Thoracic Imaging 2003 1
•Grimes et al. Respiration 2001 1
•Aksamit Respir Infect 2003 9
•Lumb et al. Appl Environ Micro 2004 4
•Systrom & Wittram NEJM 2005 1
TOTAL 41
![Page 19: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/19.jpg)
![Page 20: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/20.jpg)
![Page 21: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/21.jpg)
Study Design
Pulmonary NTMSource of infection
… Multiple respiratory samples and shower and bathtub specimens grew MAC, with matching PFGE patterns…
Hypersensitivity Pneumonitis Reaction to Mycobacterium avium in Household Water*Theodore K. Marras, MD; Richard J. Wallace, Jr., MD, FCCP; Laura L. Koth, MD; Michael S. Stulbarg, MD;† Clayton T. Cowl,
MD, FCCP; and Charles L. Daley, MD
(CHEST 2005; 127:664–671)
![Page 22: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/22.jpg)
Pulmonary NTMSource of infection
… M. avium isolated from showerhead water and biofilm in the home of a woman with M. avium disease. DNA fingerprinting demonstrated identical M. avium isolates from showerhead and patient …
Mycobacterium avium in a shower linked to pulmonary diseaseJoseph O. Falkinham III, Michael D. Iseman, Petra de Haas and Dick van Soolingen
J Water Health 06(2):209–213
![Page 23: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/23.jpg)
![Page 24: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/24.jpg)
Study DesignOccupational soil exposure - risk factor
for MAC skin test reactivity
MAC skin testing- Soil exposure
![Page 25: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/25.jpg)
Study DesignOccupational soil exposure - risk factor
for MAC skin test reactivity
MAC skin testing- Soil exposure
Study Population Risk FactorOdds Ratio
(95% CI)P
value
ReedAm J Epi 2006
Random sample, West Palm Beach FL (N=447)
Soil occupation (> 6 years)
2.7(1.3-6.0)
0.01
KhanAJRCCM 2007
Representative sample, USA (N=7,384)
Farming / Construction
1.43(1.07-1.92)
0.02
![Page 26: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/26.jpg)
Study DesignOccupational soil exposure - risk factor
for MAC skin test reactivity
MAC skin testing- Soil exposure
Study Population Risk FactorOdds Ratio
(95% CI)P
value
ReedAm J Epi 2006
Random sample, West Palm Beach FL (N=447)
Soil occupation (> 6 years)
2.7(1.3-6.0)
0.01
KhanAJRCCM 2007
Representative sample, USA (N=7,384)
Farming / Construction
1.43(1.07-1.92)
0.02
![Page 27: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/27.jpg)
Study DesignOccupational soil exposure - risk factor
for MAC skin test reactivity
MAC skin testing- Soil exposure
Study Population Risk FactorOdds Ratio
(95% CI)P
value
ReedAm J Epi 2006
Random sample, West Palm Beach FL (N=447)
Soil occupation (> 6 years)
2.7(1.3-6.0)
0.01
KhanAJRCCM 2007
Representative sample, USA (N=7,384)
Farming / Construction
1.43(1.07-1.92)
0.02
![Page 28: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/28.jpg)
High numbers of … M. avium, M. intracellulare, and M. chelonae, recovered from aerosols produced by pouring commercial potting soil and potting soil samples provided by patients with pulmonary mycobacterial infections.
Dominant mycobacteria in soil samples corresponded to dominant species implicated clinically. Pulsed-field gel electrophoresis demonstrated a closely related pair of M. avium isolates recovered from a patient and from that patient’s own potting soil.
App Env Microbiol 2006; 72:7602-6.
Pulmonary NTMSource of infection
![Page 29: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/29.jpg)
Management of pMAC
![Page 30: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/30.jpg)
“Making the diagnosis of NTM lung disease does not, per se, necessitate the institution of therapy, which is a decision based on potential risks and benefits of therapy for individual patients”
- ATS / IDSA 2007
ATS / IDSA guidelines- Diagnosis Treatment
Symptoms + Imaging + Cultures
= NTM Disease
![Page 31: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/31.jpg)
“Making the diagnosis of NTM lung disease does not, per se, necessitate the institution of therapy, which is a decision based on potential risks and benefits of therapy for individual patients”
- ATS / IDSA 2007
ATS / IDSA guidelines- Diagnosis Treatment
Symptoms + Imaging + Cultures
= NTM Disease
![Page 32: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/32.jpg)
When to treat?Micro– Repeated isolates / AFB smear +
Symptoms– Systemic* – fatigue, fever/sweat, weight loss – Local – cough, sputum, hemoptysis, dyspnea
Significant burden on imaging– Consolidation, nodules, cavities …– Progression
Pulmonary NTM- Diagnosis Treatment
![Page 33: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/33.jpg)
Non-destructive infection• CureLocalized destruction• Cure (?)Diffuse destruction• SuppressSevere drug intolerance• SuppressRecurrence• Cure or Suppress?
Pulmonary MAC- Goals of treatment
![Page 34: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/34.jpg)
Non-destructive infection• CureLocalized destruction• Cure (?)Diffuse destruction• SuppressSevere drug intolerance• SuppressRecurrence• Cure or Suppress?
Pulmonary MAC- Goals of treatment
![Page 35: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/35.jpg)
Non-destructive infection• CureLocalized destruction• Cure (?)Diffuse destruction• SuppressSevere drug intolerance• SuppressRecurrence• Cure or Suppress?
Pulmonary MAC- Goals of treatment
![Page 36: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/36.jpg)
Non-destructive infection• CureLocalized destruction• Cure (?)Diffuse destruction• SuppressSevere drug intolerance• SuppressRecurrence• Cure or Suppress?
Pulmonary MAC- Goals of treatment
![Page 37: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/37.jpg)
Non-destructive infection• CureLocalized destruction• Cure (?)Diffuse destruction• SuppressSevere drug intolerance• SuppressRecurrence• Cure or Suppress?
Pulmonary MAC- Goals of treatment
![Page 38: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/38.jpg)
ATS / IDSA guidelines- Drug treatment – MAC
Drug / classDisease type
Fibronodular Cavitary or Advanced / recurrent
MACROLIDEClari 1000 tiw or
Azi 500-600 tiw
Clari 500-1000 qd
or
Azi 250-300 qd
Ethambutol 20-25 mg/kg tiw 15 mg/kg/d
Rifamycin RMP 600 tiw
RMP 450-600 qd
or
RFB 150-300 qd
Amikacin (SM, KM)
Not recommendedConsider / recommended
(10-15 mg/kg/d)
![Page 39: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/39.jpg)
ATS / IDSA guidelines- Drug treatment – MAC
Drug / classDisease type
Fibronodular Cavitary or Advanced / recurrent
MACROLIDEClari 1000 tiw or
Azi 500-600 tiw
Clari 500-1000 qd
or
Azi 250-300 qd
Ethambutol 20-25 mg/kg tiw 15 mg/kg/d
Rifamycin RMP 600 tiw
RMP 450-600 qd
or
RFB 150-300 qd
Amikacin (SM, KM)
Not recommendedConsider / recommended
(10-15 mg/kg/d)
Other agents - Fluoroquinolones, clofazimine, linezolid
![Page 40: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/40.jpg)
When to stop?Sputum cultures negative for 12 months
Pulmonary NTM- Treatment duration
![Page 41: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/41.jpg)
Comprehensive management
![Page 42: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/42.jpg)
• Start with guidelines• Expect drug intolerance (staggered start)• Macrolides whenever possible• Amikacin for advanced cases*• Fluoroquinolones, clofazimine, linezolid as needed /
tolerated• Aim for >3 drugs*
– More drugs, higher doses greater efficacy
• Tailor therapy– Switch drugs to minimize AE’s– Re-evaluate objectives based on response, toxicity
* When treating intensively
Pulmonary MAC- Drugs
![Page 43: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/43.jpg)
Other interventions• Nutrition• Bronchodilators /
Inhaled steroids?• Pulmonary hygiene• Surgery• Avoid exposure
– Hot tubs– Shower?
Pulmonary MAC- Treatment – Other
![Page 44: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/44.jpg)
Other interventions• Nutrition• Bronchodilators /
Inhaled steroids?• Pulmonary hygiene• Surgery• Avoid exposure
– Hot tubs– Shower?
Pulmonary MAC- Treatment – Other
![Page 45: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/45.jpg)
Other interventions• Nutrition• Bronchodilators /
Inhaled steroids?• Pulmonary hygiene• Surgery• Avoid exposure
– Hot tubs– Shower?
Pulmonary MAC- Treatment – Other
![Page 46: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/46.jpg)
Other interventions• Nutrition• Bronchodilators /
Inhaled steroids?• Pulmonary hygiene• Surgery (?)
Pulmonary MAC- Treatment – Other
![Page 47: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/47.jpg)
Pulmonary MAC- Following patients on therapy
Assess responseMicrobiologic – sputum q 2-4 monthsClinical – periodicRadiographic – LDCT scan 4-6 mo, then q 6-12 mo
Follow for drug toxicities• Education important toxicity stop drugs• Clinical• Rifamycin CBC, liver tests• Ethambutol visual acuity, colour etc.• Amikacin ‘lytes, creatinine, serum level, audiograms
![Page 48: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/48.jpg)
Outcomes
![Page 49: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/49.jpg)
Clinical practice (geographic region)• Leeds, UK; MAC 1999-2001
• 41% disease recurrence or mortality at 2 years post treatment
Henry, ERJ 2004
pNTM – a chronic disease?- Clinical practice
![Page 50: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/50.jpg)
Clinical practice (specialty clinic)• 50% didn’t achieve sputum culture
conversion
• 60% didn’t tolerate initial antibiotics
• 85% remain symptomaticHuang, Chest
1999
pNTM – a chronic disease?- Clinical practice
![Page 51: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/51.jpg)
Study Rx (months)
N Sputum convert (%) Success (%)
PP ITT PP ITT
Dautzenberg ’95 12 39 77 65 77 65
Wallace ’96 > 5 48 97 75 86 67
Roussel ‘98 15 29 67 48 57 41
Griffith ’98 > 6 68 66 56 66 56
Tanaka ’99 6 46 72 61 63 48
Huang ’99 >12 27 71 37 36 19
Griffith ‘00 > 6 59 78 54 78 54
Griffith ‘01 12 103 61 54 61 54
Field ’02 > 5 30 100 87 81 70
Kobashi ‘03 12 71 58 58 32 32
Fujikane ’05 >6 137 97 79 82 66
Lam ’06 12 91 21 13 83 53
Kobashi ’07 24 73 57 51 14 12
Kobashi ’07 24 146 61 61 18 18
Jenkins ’08 24 170 90 90 33 33
Total (weighted) - 1,137 72% 62% 50% 43%
pNTM – a chronic disease?- Clinical studies
![Page 52: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/52.jpg)
StudyFollow-up (months)
NRecurrence
N %
Huang ’99 <72 27 3/10 30Kobashi ’07 36-48 73 21/37 57Kobashi ’07 36 146 29/89 33Total (weighted) - 246 53/136 39%
pNTM – a chronic disease?- Recurrence
![Page 53: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/53.jpg)
Treatment– Poorly tolerated– Suboptimal efficacy
Pulmonary MAC (NTM)- Chronicity
![Page 54: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/54.jpg)
Treatment– Poorly tolerated– Suboptimal efficacy
Cause(s) not identified or reversible– Host defect– Exposure remains…
Pulmonary MAC (NTM)- Chronicity
![Page 55: Danger in the Water Theodore Marras MD FRCPC University of Toronto & University Health Network](https://reader036.vdocuments.us/reader036/viewer/2022062421/56649e415503460f94b32a3f/html5/thumbnails/55.jpg)
Am J Resp Crit Care Med 2007, 175:367-416 Canadian Tuberculosis Standards, 6th ed
www.ntminfo.org